https://www.selleckchem.com/products/erastin.html
001). In subjects with lower limb lymphedema PREV was 80.7% (interquartile range, 74.9-85.2%) and 64.5% (interquartile range, 56.0-68.1%) for groups A and B, respectively (p less then 0.001). Duration of lymphedema was found to be a strong predictive factor that may significantly impact CDT efficacy. Therapeutic effects were increased in subjects who were detected and treated earlier for lymphedema.In a thought experiment, a "washing machine" model is proposed based on turbulent flow from complex multi-dimensional forces to characterize
Like
Comment
Share
